These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 78081)
1. Radionucleotide ejection fraction and prediction of doxorubicin cardiotoxicity. Morgan GW; Choy D; Freedman A Lancet; 1978 Jun; 1(8077):1315-6. PubMed ID: 78081 [No Abstract] [Full Text] [Related]
2. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880 [TBL] [Abstract][Full Text] [Related]
3. Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity. Steinberg JS; Wasserman AG Clin Ther; 1985; 7(6):660-7. PubMed ID: 3907840 [TBL] [Abstract][Full Text] [Related]
4. Systolic time interval to predict doxorubicin cardiotoxicity. Al-Ismail SA; Whittaker JA Lancet; 1978 Jun; 1(8077):1315. PubMed ID: 78080 [No Abstract] [Full Text] [Related]
5. Radionuclide ejection fraction in doxorubicin cardiotoxicity. Morgan GW; McIlveen BM; Freedman A; Murray IP Cancer Treat Rep; 1981; 65(7-8):629-38. PubMed ID: 7248982 [TBL] [Abstract][Full Text] [Related]
6. Serial assessment of doxorubicin cardiotoxicity in pediatric patients with quantitative radionuclide angiocardiography. Moodie DS; Dyment PG; Napoli C; Cook SA Cleve Clin Q; 1980; 47(4):327-31. PubMed ID: 7471466 [No Abstract] [Full Text] [Related]
7. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies. Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070 [TBL] [Abstract][Full Text] [Related]
8. Cardiac gallium uptake in doxorubicin-induced cardiotoxicity. Hatfield MK; Martin WB; Ryan JW; Vokes EE; Vogelzang NJ Clin Nucl Med; 1986 Nov; 11(11):756-7. PubMed ID: 3791781 [TBL] [Abstract][Full Text] [Related]
9. Selective right ventricular dysfunction following doxorubicin therapy. Sperber AD; Cantor AA; Biran H; Keynan A Isr J Med Sci; 1987 Aug; 23(8):896-9. PubMed ID: 3679793 [TBL] [Abstract][Full Text] [Related]
10. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value. Skubitz KM; Blaes AH; Konety SH; Francis GS Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562 [TBL] [Abstract][Full Text] [Related]
11. Testing for doxorubicin cardiotoxicity. Henderson IC; Frei E N Engl J Med; 1979 Jun; 300(24):1393-4. PubMed ID: 440374 [No Abstract] [Full Text] [Related]
13. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365 [TBL] [Abstract][Full Text] [Related]
14. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. Batist G; Ramakrishnan G; Rao CS; Chandrasekharan A; Gutheil J; Guthrie T; Shah P; Khojasteh A; Nair MK; Hoelzer K; Tkaczuk K; Park YC; Lee LW J Clin Oncol; 2001 Mar; 19(5):1444-54. PubMed ID: 11230490 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. Speyer JL; Green MD; Kramer E; Rey M; Sanger J; Ward C; Dubin N; Ferrans V; Stecy P; Zeleniuch-Jacquotte A N Engl J Med; 1988 Sep; 319(12):745-52. PubMed ID: 3137469 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity. Zhu J; Zhang J; Xiang D; Zhang Z; Zhang L; Wu M; Zhu S; Zhang R; Han W Eur J Pharmacol; 2010 Sep; 643(2-3):247-53. PubMed ID: 20599921 [TBL] [Abstract][Full Text] [Related]